Literature DB >> 15114004

Construction and isolation of recombinant vaccinia virus using genetic markers.

María M Lorenzo1, Inmaculada Galindo, Rafael Blasco.   

Abstract

The standard approach for the isolation of vaccinia virus recombinants involves homologous recombination between a transfected plasmid and the replicating viral DNA. In a typical infection/transfection experiment, recombinant viruses only account for a tiny proportion (10-4 to 10-3) of the progeny virus; thus, genetic markers are often included in the transfected plasmid to facilitate the selection of recombinant viruses. This chapter describes in detail two different selection procedures: one relies on plaque formation phenotype using the vaccinia virus gene F13L; the other relies on antibiotic resistance using the Escherichia coli xanthine-guanine phosphoribosyl transferase gene.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15114004     DOI: 10.1385/1-59259-789-0:015

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  14 in total

1.  N1L is an ectromelia virus virulence factor and essential for in vivo spread upon respiratory infection.

Authors:  Meike S Gratz; Yasemin Suezer; Melanie Kremer; Asisa Volz; Monir Majzoub; Kay-Martin Hanschmann; Ulrich Kalinke; Astrid Schwantes; Gerd Sutter
Journal:  J Virol       Date:  2011-01-26       Impact factor: 5.103

2.  Characterization of ectromelia virus deficient in EVM036, the homolog of vaccinia virus F13L, and its application for rapid generation of recombinant viruses.

Authors:  Felicia Roscoe; Ren-Huan Xu; Luis J Sigal
Journal:  J Virol       Date:  2012-10-03       Impact factor: 5.103

3.  Generation of recombinant vaccinia viruses via green fluorescent protein selection.

Authors:  Sergei Popov; Saied Mirshahidi; Sosthène Essono; Ruijiang Song; Xiaowei Wang; Ruth M Ruprecht
Journal:  DNA Cell Biol       Date:  2009-03       Impact factor: 3.311

4.  A novel, killed-virus nasal vaccinia virus vaccine.

Authors:  Anna U Bielinska; Alexander A Chepurnov; Jeffrey J Landers; Katarzyna W Janczak; Tatiana S Chepurnova; Gary D Luker; James R Baker
Journal:  Clin Vaccine Immunol       Date:  2007-12-05

5.  Generation of recombinant Orf virus using an enhanced green fluorescent protein reporter gene as a selectable marker.

Authors:  Zhangyong Ning; Yongzheng Peng; Wenbo Hao; Chaohui Duan; Daniel L Rock; Shuhong Luo
Journal:  BMC Vet Res       Date:  2011-12-22       Impact factor: 2.741

6.  A vaccinia virus recombinant transcribing an alphavirus replicon and expressing alphavirus structural proteins leads to packaging of alphavirus infectious single cycle particles.

Authors:  Juana M Sánchez-Puig; María M Lorenzo; Rafael Blasco
Journal:  PLoS One       Date:  2013-10-09       Impact factor: 3.240

7.  Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.

Authors:  David C J Carpentier; Michael S Hollinshead; Helen A Ewles; Stacey-Ann Lee; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

Review 8.  CRISPR/Cas9-Advancing Orthopoxvirus Genome Editing for Vaccine and Vector Development.

Authors:  Arinze Okoli; Malachy I Okeke; Morten Tryland; Ugo Moens
Journal:  Viruses       Date:  2018-01-22       Impact factor: 5.048

9.  Loss of Actin-Based Motility Impairs Ectromelia Virus Release In Vitro but Is Not Critical to Spread In Vivo.

Authors:  Melanie Laura Duncan; Jacquelyn Horsington; Preethi Eldi; Zahrah Al Rumaih; Gunasegaran Karupiah; Timothy P Newsome
Journal:  Viruses       Date:  2018-03-05       Impact factor: 5.048

10.  Vaccinia virus egress mediated by virus protein A36 is reliant on the F12 protein.

Authors:  David C J Carpentier; Alexander Van Loggerenberg; Nele M G Dieckmann; Geoffrey L Smith
Journal:  J Gen Virol       Date:  2017-06-20       Impact factor: 3.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.